Table 6. Number of cycles with serious adverse events.
| Serious adverse event | Overall (95% CI) | Anthracycline (95% CI) | Non-anthracycline (95% CI) |
|---|---|---|---|
| Neutropenia | 2.3 (2.16-2.47) | 2.4 (2.22-2.55) | 1.9 (1.56-2.25) |
| Febrile neutropenia | 1.3 (1.16-1.35) | 1.13 (1.15-1.38) | 1.2 (1.01-1.41) |
| Asthenia | 1.4 (1.26-1.51) | 1.4 (1.27-1.54) | 1.1 (0.79-1.49) |
| Peripheral sensory neuropathy | 1.2 (1.17-1.31) | 1.2 (1.16-1.30) | 1.3 (1.00-1.54) |
CI=confidence interval.